Astero Bio

Menlo Park, United States Founded: 2018 • Age: 8 yrs Acquired By BioLife Solutions
Tools and technologies for life science research are developed.

About Astero Bio

Astero Bio is a Healthcare company based in Menlo Park (United States) founded in 2018, and was acquired by BioLife Solutions in March 2019. Tools and technologies for life science research are developed. The company was acqui-hired. Astero Bio offers products and services including Registration Service. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Lab Automation. Its competitors include Pressure BioSciences and Inso Bio; 1 of its 2 listed competitors has raised funding.

Company details

Astero Bio was founded in 2018 and is based in Menlo Park, United States. Operations focus on the development of tools for life science research and the pharmaceutical sector. Products include ThawSTAR, an automated system for cell thawing that employs a customizable algorithm, and BioT Transporter, a portable device for handling temperature-sensitive frozen biosamples during transport. These tools support various stages in the lifecycle of biologics.

  • Headquarters Menlo Park, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website asterobio.com
  • Social LinkedIn X
  • Acquired by BioLife Solutions (Mar 2019)
Key Metrics

Products & Services of Astero Bio

Astero Bio offers a comprehensive portfolio of products and services, including Registration Service.

Registration Service
Online Platform

Facilitates user sign-ups for sports betting sites

Investors in Astero Bio

Astero Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BioLife Solutions.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Tissue hypothermic storage and cryopreservation freeze media are developed.
1987biolifesolutions.comBothell, United States
Premium access

Investor details for Astero Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Astero Bio

2 dated milestones of Astero Bio across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Astero Bio is founded.
  2. Exit Acquired by BioLife Solutions.

Competitors of Astero Bio

Astero Bio has 2 listed competitors in our database, 1 of them funded. They include Pressure BioSciences and Inso Bio.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
pressurebiosciences.com1978Easton, United States15
Biomolecular reactions are controlled via pressure cycling technology.
inso.bio2020Ithaca, United States$2.45M
Microfluidic automated devices for cellular sample preparation are developed.
Premium access

Detailed competitors of Astero Bio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Astero Bio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Astero Bio

Premium access

Complete news archive for Astero Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Astero Bio

Astero Bio was founded in 2018.

Astero Bio is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.

Astero Bio was founded in 2018 and is based in Menlo Park, United States. Operations focus on the development of tools for life science research and the pharmaceutical sector. Products include ThawSTAR, an automated system for cell thawing that employs a customizable algorithm, and BioT Transporter, a portable device for handling temperature-sensitive frozen biosamples during transport. These tools support various stages in the lifecycle of biologics.

Astero Bio's top competitors include Pressure BioSciences and Inso Bio.

Astero Bio offers Registration Service.

Astero Bio has 1 investor. Key investors include BioLife Solutions.

Yes. Astero Bio was acquired by BioLife Solutions in March 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available